Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
GSK Consumer Healthcare Requests Halt of Excedrin Sale & Teva Pharmaceuticals Releases Generic Truvada
Excedrin Lots On October 7, 2020, GSK Consumer Healthcare requested retailers halt sales of certain Excedrin lots.
Mitchell
News Release
Rising Opioid Abuse, Increasing Acceptance of Marijuana and COVID-19 Continue to Shape Pharmacy Programs
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Blog
Clinical Cannabis Considerations
It seems there is always something new to say when it comes to the hot topic of medical marijuana or “cannabis,” as it’s commo
Workers' Comp
Blog
Keys to Building Relationships
As Case Management Week c
Auto Casualty
Article
Success Story: New AI Model Helps CCMSI Seal the Cracks in the Claims Cycle
Download a PDF Version of this Article CCMSI, a large boutique thi
Mitchell
News Release
Mitchell Names CCMSI a 2020 mPower Customer Award Winner
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the